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VALVULAR DISEASE
Mitral Valve Prolapse: Is it Associated with Acute
Ischemic Neurologic Events?
PBV (I vs II)
NHV (III vS IV)
PBV-Ca2+ and NHV-Ca2+ (II vs III)
PBV-Ca2+ vs NHV-NonCa2+
* Significant p value by Fisher's Exact Test
Cellular Expression of Matrix Proteins Mediates
Calcification in Native Human and Bioprosthetic
Heart Valves
Sanjay Srivatsa, Philip Harrity, William Edwards, Christopher Johnson,
Lorraine Fitzpatrick. Mayo Clinic and Mayo Foundation, Rochester, MN
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A high frequency of association has previously been reported between acute
ischemic neurological events and mitral valve prolapse (MVP), especially in
young patients I<45 years old), primarily based on M-mode scans. Criteria for
diagnosing MVp, however, have subsequently changed based on 3D analysis
of valve shape and clinical correlations, greatly decreasing its prevalence. It
is therefore necessary to reconsider associations previously described using
nonspecific M-mode and two-dimensional (2D) echo criteria. We retrospec-
tively reviewed all echo studies performed from 1985 to 1994 in patients
<45 years old referred by their physician because of stroke or transient is-
chemic attack looking for source of embolus. Patients with known or poten-
tial sources such as prosthetic heart valves, intracardiac masses, dilated or
aneurysmal LV. or congenital heart defects were excluded. MVP was evalu-
ated using 2D echo criteria now widely accepted (in long-axis views, exclud-
ing nonspecific anterior leaflet displacement in the 4-chamber view; these
criteria correlate with valve dysfunction and valve-related complications). Re-
sults: Ofthe 244 patients evaluated, only 3 (1.2%) had MVP (anterior, posterior
and bileaflet with thin valves and normal LA size). All 3 patients also had a
patent foramen ovale with shunt. Discussion: Earlier studies using less spe-
cific M-mode criteria found MVP in up to 40% of young patients with stroke
or TIA, but also in 7-21 % of otherwise healthy individuals. In contrast, the
very low prevalence of MVP in the present group of patients, despite referral
for echocardiography (potential bias towards the diagnosis), suggests the
association is much smaller, possibly at the level of random association.
Conclusion: The linkage ofMVP and acute ischemic neurological events in
the young, therefore, could not be demonstrated by more recent validated
and accepted 2D echo criteria in an echocardiographic referral population.
Dystrophic mineralization remains the leading cause of valve stenosis and
failure in native human (NHV) and porcine bioprosthetic (PBV) heart valves.
We hypothesized that expression of noncollagenous matrix proteins (MP)
that induce skeletal mineralization may orchestrate valvular calcification
(Ca 2+). 18 porcine PBV and 13 NHV obtained during replacement surgery
were analysed for cells, calcium, fibrosis and vessels. Immunostaining for
macrophages, T-cells, a-smooth muscle (SM) actin, osteopontin (OP), os-
teocalcin (OC) and osteonectin (ON) was performed with non-immune sera
as controls. In situ hybridization analysis utilized antisense oligonucleotide
probes for OR OC, ON and sense controls. Results were compared to known
positive/negative tissue controls and normal heart valves. A probe averaged
in situ score was calculated for each valve. MP in situ was graded positive
if ~2 different probes exhibited >5 signal positive cells/slide. Valves were
divided into 4 groups based on presence of calcium: I: PBV non-Ca2+ (n =
8); II: PBV-Ca2+ (n = 10); III: NHV-Ca2+ (n = 8); IV: NHV non-Ca2+ (n = 5). 2
x 2 contingency table analysis of in situ signal status revealed:
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Positive
versus
negative
in situ
Comparison of mean in situ scores revealed significant differences among
groups III vs IV and I vs IV PBV age (p < 0.001) and NHV cellularity (p < 0.003)
correlated with calcium. For all valves: OR OC and ON mRNA expression lo-
calized with calcification and cellular infiltration; immunostaining identified
macrophages, OR OC and ON at the calcification front; SM were associated
with valve edges and cuspal Ca2+ Conclusions: (1) Cell-mediated calcifica-
tion is promoted by matrix protein expression common to PBV and NHV;
(2) matrix protein mRNA expression is quantitatively related to extent and
localization of valvular mineralization; (3) macrophage infiltration is closely
associated with matrix protein expression and calcification.
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Coronary Vascular Relaxation Induced by
Testosterone In Vivo is Gender Independent
Tony M. Chou, Krishnankutty Sudhir, Thomas M. Amidon, Peter Collins, Paul
G. Yock, Kanu Chatterjee. University of California, San Francisco, CA
Variables Rest Exercise
Drug-Free Estrogen Drug-Free Estrogen
SBPlmmHg) 142 ± 24 131 ± 21' 186 ± 33 181 ± 31
DP (SBPxHR) 9987 ± 2503 9087 ± 1422' 27300 ± 9079 26432 ± 6821
LVEDD (em) 4.4 ± 0.4 4.4 ± 0.6 4.3 ± 0.4 4.0 ± 0.7
LVESD (em) 3.0 ± 0.6 29 ± 0.7 2.7 ± 0.6 2.5 ± 0.7
Beneficial Effects of Estrogen Replacement
Therapy on Cardiovascular Hemodynamics in
Postmenopausal Women
Millie Lee, Stephanie R. Bruce, Nan Garber, Henry Wu, George Shapiro, Marco Di
Tullio, Shunichi Homma, Elsa-Grace V. Giardina. Center for Women's Health.
Columbia University. New York, NY
JACC February 1995
Estrogen replacement therapy (ERT) in postmenopausal women reduces the
risk of fatal and nonfatal coronary artery disease (CAD). The mechanism of
the beneficial effect is not yet fully explained, although changes in plasma
lipoproteins and a direct vasodilatory effect have been suggested, To inves-
tigate the effect of standard oral ERT. we performed exercise echocardio-
graphy in 11 postmenopausal women (mean age 62 ± 8 years). Subjects
were randomized to 0.625 mg conjugated oral equine estrogen or no active
treatment for 30 days, with crossover after a 4 to 6 week washout period. At
rest and at peak exercise, systolic blood pressure (SBP), heart rate (HR), left
ventricular end-systolic (LVESD) and end-diastolic (LVEDD) diameters were
measured and cardiac double product (DP) calculated at baseline and after
each treatment. The results follow:
more frequently than men. In conclusion, women demonstrated a greater
antihypertensive effect to amlodipine than men; the mechanism for this ob-
servation remains to be determined,
'p < 0.05, 'p ~ 005
Conclusion: Short-term ERT reduces systolic blood pressure, double prod-
uct and LV diameters at rest and after exercise. These observations suggest
that the beneficial mechanism of ERT in postmenopausal women may be
mediated via a reduction in cardiac afterload.
To assess coronary vasoreactive response of testosterone and its relation
to gender, we examined the effect of intracoronary testosterone (10- 10 to
10-6M) on epicardial and resistance coronary arteries in vivo in both male
(5) and female (5) dogs, Changes in average peak flow velocity (APV) were
assessed using a 0.014" Doppler guidewire (Cardiometrics), and epicardial
cross-sectional area (CSA) was measured using a 4.3 F, 30 MHz ultrasound
imaging catheter (CVIS). Guidewire and imaging catheter were positioned
in the left circumflex artery. Testosterone induced a significant increase in
both CSA, APV and calculated volumetric coronary blood flow (CBFI at the
10-7 and 1O-6M concentrations (CSA: 15.2 ± 10.2% increase at 1O-6M (p
= 0.05); APV: 36.4 ± 12.8 increase at 10-7 (p < 0,01) and 73.8 ± 66.8%
increase at 10-6M (p ~ 0.004); CBF: 205% increase at 10-6M (p = 0.04)1.
Coronary vasorelaxation was equal in both males and females. No significant
changes in heart rate or systemic pressure were noted.
Conclusion: We conclude that acute testosterone administration induces
epicardial and resistance coronary artery dilation in vivo and coronary vasore-
laxation is independent of gender.
